Radiotherapy with or without ibandronate [ibandronic acid] in the treatment of painful bone metastases of prostate cancer
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 16 Sep 2011
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- Sponsors Roche
- 19 Jan 2010 New source identified and integrated (Netherlands Trial Register).
- 08 Feb 2006 New trial record.